Western blot analysis also showed results consistent with immunohistochemical results in that MEF2 expression in MI hearts transplanted with cardiogenin-activated MSCs was ∼2.6 folds more than that in those transplanted with cardiogenin-noggin-treated MSCs (Fig. 6h). The gene discussed is NOG; the disease is myocardial infarction.